0001387131-21-009808.txt : 20211006
0001387131-21-009808.hdr.sgml : 20211006
20211006170335
ACCESSION NUMBER: 0001387131-21-009808
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211001
FILED AS OF DATE: 20211006
DATE AS OF CHANGE: 20211006
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Desai Meera J.
CENTRAL INDEX KEY: 0001886559
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36242
FILM NUMBER: 211310328
MAIL ADDRESS:
STREET 1: 1682 EL CAMINO REAL
STREET 2: STE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp
CENTRAL INDEX KEY: 0000887247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820429727
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11682 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 997-2400
MAIL ADDRESS:
STREET 1: 11682 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19950615
4
1
mdesai-form4_100121.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2021-10-01
0
0000887247
Adamis Pharmaceuticals Corp
ADMP
0001886559
Desai Meera J.
C/O ADAMIS PHARMACEUTICALS CORPORATION
11682 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
1
0
0
0
Stock Appreciation Right
1.01
2021-10-01
4
A
0
50000
0
A
2028-10-01
Common Stock
50000
50000
D
Each Stock Appreciation Right is the economic equivalent of one share of ADMP common stock and can only be settled in cash.
The Stock Appreciation Right ("SAR") will vest with respect to 1/6 of the shares subject to the SAR on the six-month anniversary of the date of grant, and thereafter with respect to 1/36 of the shares on each monthly anniversary of the date of grant with all remaining unvested shares subject to the SAR vesting on the thirty-sixth (36th) monthly anniversary of the date of grant.
/s/ David C. Benedicto, as Attorney-in-Fact
2021-10-06